K
Kenneth J. Pienta
Researcher at Johns Hopkins University School of Medicine
Publications - 751
Citations - 72579
Kenneth J. Pienta is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 127, co-authored 671 publications receiving 64531 citations. Previous affiliations of Kenneth J. Pienta include Rutgers University & Harper University Hospital.
Papers
More filters
Journal ArticleDOI
Metastasis Directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-Resistant Prostate Cancer
Matthew P. Deek,Kekoa Taparra,Ryan Phillips,P. Isaacsson Velho,R.W. Gao,Curtiland Deville,Danny Y. Song,Stephen Greco,Michael A. Carducci,Mario A. Eisenberger,T.L. DeWeese,Samuel R. Denmeade,Kenneth J. Pienta,Channing J. Paller,Emmanuel S. Antonarakis,Kenneth R. Olivier,S.S. Park,Phuoc T. Tran,Bradley J. Stish +18 more
Journal ArticleDOI
Diagnostic performance of 18F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC).
Michael J. Morris,Jeremy C. Durack,Ajjai Alva,Hebert Alberto Vargas,Morand Piert,Russell K. Pachynski,Frédéric Pouliot,Jean-Mathieu Beauregard,Mark A. Preston,Atish D. Choudhury,Lawrence Saperstein,Peter R. Carroll,Steven P. Rowe,Kenneth J. Pienta,Tess Lin,Vivien Wong,Melissa Nichols,Jessica Jensen,Barry A. Siegel +18 more
TL;DR: 18F-DCFPyL is a novel PET imaging method for prostate cancer detection that shows high precision in detecting mPC and low uncertainty in its sensitivity to prostate cancer cells.
Journal ArticleDOI
Electroretinographic findings in subjects after administration of fenretinide
TL;DR: The results indicate that men taking 100 mg of oral fenretinide per day for 1 year, with a 3 day hiatus each month, do not show toxicity -induced retinal dysfunction, as measured by the electroretinogram.
Journal Article
Establishment of an immortalized Copenhagen rat bone marrow endothelial cell line.
TL;DR: An immortal cell line of Copenhagen rat bone marrow endothelium was established after infection of primary cultured cells with Adenovirus-12 SV40 hybrid virus and designated YPBE-1, which stains positively for SV40 T-antigen in its nuclei by immunohistochemistry.
Ten unanswered questions in cancer: "If this is true, what does it imply"?
Amend,de Groot Ae,Gonzalo Torga,Haley D. Axelrod,Reyes Dk,Kenneth C. Valkenburg,Stephanie Glavaris,Kenneth J. Pienta +7 more
TL;DR: The disorganized structure and function of cancer cells only touches the surface of the myriad of unanswered questions associated with the evolution of a cancer cell to not only form a successful primary tumor, but also to genotypically and phenotypically adapt to different and changing environments resulting in a metastatic, lethal disease.